INFUSYSTEM HOLDINGS, INC Number of Reportable Segments
INFUSYSTEM HOLDINGS, INC (INFU) reported Number of Reportable Segments of 2 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC number of reportable segments for the quarter ending 2020-03-31 was 200.00%.
- INFUSYSTEM HOLDINGS, INC number of reportable segments for the quarter ending 2019-12-31 was 200.00%.
- INFUSYSTEM HOLDINGS, INC number of reportable segments for fiscal 2020 was 200.00%.
pure
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2020-12-31 | 200.00% 10-K · filed 2021-03-22 | |||
| 2020-09-30 | 200.00% 10-Q · filed 2020-11-13 | |||
| 2020-06-30 | 200.00% 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | 200.00% 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | 200.00% 10-K · filed 2021-03-22 | |||
| 2019-09-30 | 100.00% 10-K · filed 2021-03-22 |
lease
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2022-12-31 | 2.00 lease 10-K · filed 2023-03-16 |
| 2021-12-31 | 2.00 lease 10-K · filed 2022-03-15 |
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.00 segment 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | 2.00 segment 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 2.00 segment 10-K · filed 2026-02-27 | |||
| 2025-09-30 | 2.00 segment 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 2.00 segment 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | 2.00 segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 2.00 segment 10-K · filed 2025-03-11 | |||
| 2024-09-30 | 2.00 segment 10-Q · filed 2024-11-08 | |||
| 2024-06-30 | 2.00 segment 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | 2.00 segment 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 2.00 segment 10-K · filed 2024-04-10 | |||
| 2023-09-30 | 2.00 segment 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 2.00 segment 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | 2.00 segment 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |